3 shares to profit from the wealthy baby boomers

In 2016, 15% of Australians were aged 65 and over. That's 3.7 million people.  By 2056, that number is projected to increase to 8.7 million people, or 22% of the population. More Australians are going to be living longer into old age, and these three companies might be poised to make a killing off of their longevity. 

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Maybe, like me, you've spent the last few years watching your beloved relatives grow to an almost impossibly healthy old age. Your email inbox and Facebook feed are regularly flooded with badly composed photos from some other sun-drenched location – smiling parents reporting back from the Mediterranean, or warm Caribbean seas, or yet another caravan park.  

And with each photo and Facebook update, you can feel your inheritance drying up. Don't they realise their recent safari in Kenya cost you a kitchen renovation? It's just rude, isn't it? You thought old people were meant to just stay home and drink prune juice – and meanwhile they're out enjoying their lives 

Surely there is some way that you could benefit from your parents' stubborn longevity and still afford that new kitchen you always dreamed of. Well, an investment in one of these three companies could be the answer. It might even help take some of the tension out of the air the next time your parents invite you over for a slideshow of their holidays.

  1. Challenger Ltd (ASX: CGF)

Challenger is an investment management firm that specialises in annuities.   

Many people cash out their super fund in one lump sum when they hit retirement, and decisions on how to manage this capital can be stressful.  

An annuity provides a guaranteed steady source of income into old age. This allows retirees to budget more effectively throughout their retirement. 

Challenger had a great FY17, with its assets under management increasing 17% on FY16 to $70 billion and statutory NPAT up 21% to $398 million. Annuity sales were up 20% to $4 billion for the year. 

The company's outlook for FY18 is for growth in normalised net profit before tax of between 8% and 12%. Given FY17 growth in NPBT was 8%, this shows that the company is optimistic about its future. 

Challenger's share price is up around 20% over the last 12 months to $14.03. 

  1. Estia Health Ltd (ASX: EHE)

Estia Health is one of the largest providers of aged care services in Australia. As life expectancy increases and a greater proportion of the nation's population moves into old age, demand for this sort of healthcare can only increase. 

There are a number of aged care providers in Australia, but Estia seems to be the pick of the bunch right now. 

Shares in Estia Health Ltd have vastly outperformed rivals Japara Healthcare Ltd (ASX: JHC) and Regis Healthcare Ltd (ASX: REG) over the last 12 months. They have surged over 30% to $3.52, while Japara's shares have fallen about 12% to $1.97, and the Regis share price is down 24% to $3.63. 

The market rewarded Estia for delivering the best financial results out of the three companies. Estia's FY17 NPAT rose 47% to $40.7 million and they halved their net debt through a successful capital raising of $136.8 million. By contrast, Regis' NPAT rose just 8% to $61.1 million, while Japara's NPAT actually fell 2.3% to $29.7 million. 

Looking at its P/E ratio relative to its peers doesn't seem to indicate that Estia's shares are that overbought either. Both Japara and Regis trade at a little under 18x earnings, whereas Estia is only slightly higher at 19.5x. Now could be an ideal opportunity to invest in a growing company at a reasonably fair price. 

  1. Invocare Limited (ASX: IVC)

This one is a little morbid, but it still deserves to be included on the list.  

Invocare operates funeral homes, cemeteries and crematoria in Australia, New Zealand and Singapore. They own a number of well-known brands, including White Lady Funerals. 

An ageing population means that death rates are also going to increase. So an investment in Invocare is almost like holding life insurance on the population. 

Invocare delivered strong results in its first half FY17 results (it reports on a financial year ending December 31). Net profit was up 50.1% on 1H16, but this was primarily driven by increased returns on prepaid contract funds under management.

These are prepaid funeral expenses that Invocare keeps in trust and invests in equities, fixed income and property. One side effect of people living longer into old age – longer than even they themselves anticipated – is that these prepaid expenses will sit on Invocare's balance sheet for longer, giving the company increased opportunity to earn returns on them. 

In 1H17, a big boost came from positive revaluations of property Invocare was invested in, and it will be interesting to see whether a similar feat can be repeated in 2H17.

However, relying on shrewd asset allocation as a key source of income will most likely add increased volatility to earnings. This may dissuade some more risk-averse investors who would rather Invocare focussed on their core business rather than branching out into funds management. 

Invocare's share price is up 14% over the last 12 months to $15.82. 

Motley Fool contributor Rhys Brock has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »